The Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception.
about
Factors Driving the HIV Epidemic in Southern Africa.The Human Microbiome during Bacterial Vaginosis.Individual and Population Level Impact of Key HIV Risk Factors on HIV Incidence Rates in Durban, South Africa.Biomarkers of Cervical Inflammation and Immunity Associated with Cervical Shedding of HIV-1Contraceptive challenges in adolescents living with or at risk of HIV.An updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women.Risk of bacterial vaginosis, Trichomonas vaginalis and Candida albicans infection among new users of combined hormonal contraception vs LNG-IUS.The Interplay of Host Immunity, Environment and the Risk of Bacterial Vaginosis and Associated Reproductive Health Outcomes.Does the vaginal microbiota play a role in the development of cervical cancer?Effects of injectable progestogen contraception versus the copper intrauterine device on HIV acquisition: sub-study of a pragmatic randomised controlled trial.Progesterone-based compounds affect immune responses and susceptibility to infections at diverse mucosal sites.Levonorgestrel in contraceptives and multipurpose prevention technologies: does this progestin increase HIV risk or interact with antiretrovirals?Misreporting of contraceptive hormone use in clinical research participants.Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms.Bacterial vaginosis modifies the association between hormonal contraception and HIV acquisition.Is a lower-dose, subcutaneous contraceptive injectable containing depot medroxyprogesterone acetate likely to impact women's risk of HIV?Sex Differences in HIV Infection.Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women.Sex Differences in HIV Infection: Mystique Versus MachismoThe relationship between sex hormones, the vaginal microbiome and immunity in HIV-1 susceptibility in women
P2860
Q30387557-B10FD716-C175-44ED-8F21-477553833437Q35920191-356F83A7-7D9F-4F1E-A2B4-3F7BD38593DAQ35996904-1ECEF035-3F75-43B4-A3FA-054CC2EDAC93Q36837376-07209A8C-C23D-4B40-A78C-80CE0AEF6938Q37136261-6D7C7AA3-8F40-4EE6-9546-1C9B27F378E5Q37409664-02B672B0-BE77-428A-A72D-8746115C99B5Q38604130-3ACD5174-895D-4713-9EAA-3DFBFAAE2264Q38801593-600910C6-78F9-4C50-A7C7-93529ADC51B9Q38835933-CE8D7612-56DE-4946-B17A-D9F5CB42C78EQ38851686-0CF586BC-ECE5-4383-A8FC-802586AD255CQ39237289-421D4C21-38BD-4AB1-B11F-A45301F5591EQ40515915-06285209-8FCA-4A67-99AC-2DF0AD29A758Q46010525-8371A236-054E-47C2-84A4-C804B80648EEQ47198102-B8A0D43E-6A5F-4972-BFE7-01FCF12F2E89Q47731889-43811C2E-CD69-4943-A33A-6D06375DB9F6Q49838895-B829D623-DA8A-4984-9444-32ED49BB26C5Q52674721-1212C7E5-E0AE-4F2B-97C0-7D8C8E77FF62Q55514511-9886E920-5C21-4AA9-9A4F-A3FA5B22FFA4Q56996082-8E78EEC0-71D6-4408-A015-F6166215D3DCQ58697026-CD605761-50F1-4C3F-A0DE-A45FB7F904EE
P2860
The Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The Contribution of Cervicovag ...... cts of Hormonal Contraception.
@ast
The Contribution of Cervicovag ...... cts of Hormonal Contraception.
@en
type
label
The Contribution of Cervicovag ...... cts of Hormonal Contraception.
@ast
The Contribution of Cervicovag ...... cts of Hormonal Contraception.
@en
prefLabel
The Contribution of Cervicovag ...... cts of Hormonal Contraception.
@ast
The Contribution of Cervicovag ...... cts of Hormonal Contraception.
@en
P2093
P2860
P356
P1433
P1476
The Contribution of Cervicovag ...... cts of Hormonal Contraception.
@en
P2093
Charles S Morrison
Christine Mauck
Cynthia Kwok
Gustavo F Doncel
Kevin Mendonca
Pai-Lien Chen
Raina N Fichorova
Robert Salata
P2860
P304
P356
10.1128/MBIO.00221-15
P577
2015-09-01T00:00:00Z